Energy And Commerce Members Want FDA Overseas Operations Update
This article was originally published in The Rose Sheet
Executive Summary
The GAO will report on foreign office closures and risk-based inspection policy amid Energy and Commerce leaders' concerns that an unequal playing field remains between domestic and foreign drug manufacturers.